Terumo (4543) Stock Price, Fundamentals & Analysis

What 4543 does

Terumo (4543) is a stock listed on the Tokyo Stock Exchange stocks in the Healthcare sector, specifically the Medical Devices industry. Headquartered in Shibuya, Japan, Terumo Corporation manufactures and sells medical products and equipment across Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies. Its product range includes angiographic guidewires, coronary stents, cerebral aneurysm coils, infusion pumps, and other medical devices. As a component of the Nikkei 225, it is often discussed alongside peers such as Astellas (4503), Hoya (7741), and Takeda Pharmaceutical (4502).

Key numbers explained

• 2,296.5 JPY is the current share price — the amount one share trades for at a given moment.
• The trailing P/E ratio of 24.9 (price-to-earnings ratio) compares the share price to the last 12 months of earnings per share; a higher number can indicate the market expects strong future growth.
• The forward P/E ratio of 22.6 uses expected future earnings, offering a look at how the market prices what is coming rather than what has already been reported.
• Dividend yield of 1.57% (dividend yield) shows the annual dividend as a percentage of the share price, useful for income-focused investors.
• The ex-dividend date of Sep 29, 2026 is the cutoff: you must own the stock before this date to receive the next dividend payment.
• Beta of 0.23 measures volatility relative to the market; a number below 1 suggests the stock tends to move less than the overall market.
• Revenue growth of 19.9% year over year indicates how much the company's top line has expanded in the trailing 12 months.
• Profit margin of 13.9% and operating margin of 28.7% show how much of each revenue yen turns into profit and operating income, respectively.

What to watch

• Earnings reports and the nextEarningsDate of Nov 12, 2026 can move the stock, as they provide updated views on growth and margins.
• The price change over the last 52 weeks of -5% and the 52-week range of 1,900 – 2,689 show the recent price context and volatility.
• The debt-to-equity ratio of 26.4% reflects the company's leverage, which can affect financial risk in changing rate environments.
• The share of earnings paid out as dividends of 33% indicates the portion of profit returned to shareholders, which can influence total return.
• Broader Healthcare and Medical Devices trends, regulatory changes, and currency movements in the JPY are general factors that can affect stocks like Terumo (4543).